The use of botulinum toxin in the treatment of adductor spasmodic dysphonia

J Neurol Neurosurg Psychiatry. 1993 May;56(5):526-30. doi: 10.1136/jnnp.56.5.526.

Abstract

Botulinum toxin injections have been used to treat 31 patients with adductor spasmodic dysphonia. Injections of 3.00-3.75 units of botulinum toxin were performed bilaterally into the thyroarytenoid muscle. This treatment significantly decreased the standard deviation of the fundamental frequency of the speech sample, indicating a reduction in the variability of pitch amongst patients. A total of 96% of patients' subjective diary reports showed an improvement with a median of 7 days to peak effect and a 5 week duration of peak effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Botulinum Toxins / administration & dosage
  • Botulinum Toxins / therapeutic use*
  • Female
  • Humans
  • Injections, Intramuscular
  • Male
  • Middle Aged
  • Muscle Spasticity / drug therapy
  • Muscle Spasticity / physiopathology*
  • Speech / drug effects
  • Vocal Cords / drug effects
  • Vocal Cords / physiopathology*
  • Voice Disorders / diagnosis
  • Voice Disorders / drug therapy*
  • Voice Disorders / physiopathology
  • Voice Quality

Substances

  • Botulinum Toxins